Literature DB >> 1979427

A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC.

P Soares-da-Silva1, M C Garrett.   

Abstract

The rates of disappearance of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of rats treated with the tyrosine hydroxylase inhibitor alpha-methyl-p-tyrosine were measured. Levels of dopamine. DOPAC and HVA in tissue were quantified in the striatum, nucleus accumbens and frontal cortex of the rat by means of high pressure liquid chromatography with electrochemical detection. Rats were sacrificed 1, 2 or 3 hr after the administration of alpha-methyl-p-tyrosine (200 mg/kg, i.p.). Levels of dopamine, DOPAC and HVA in tissue were logarithmically transformed, plotted against the duration of inhibition of tyrosine hydroxylase and the rate constant of the decline of dopamine and of its metabolites calculated. The rate constant of decline of DOPAC in each of brain studied was found to be greater than that for dopamine. The rate constant for the decline of dopamine was found to be greater in areas of the brain presenting the largest DOPAC/dopamine tissue ratios (frontal cortex greater than nucleus accumbens greater than striatum). The present results suggest that a substantial amount of DOPAC in brain derives from a newly formed pool of dopamine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979427     DOI: 10.1016/0028-3908(90)90135-e

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry.

Authors:  Holger Fuchs; Wolfgang Hauber
Journal:  Exp Brain Res       Date:  2003-09-24       Impact factor: 1.972

2.  Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.

Authors:  Elaine Del-Bel; Fernando Eduardo Padovan-Neto; Raphael Escorsim Szawka; Célia Aparecida da-Silva; Rita Raisman-Vozari; Janete Anselmo-Franci; Angélica Caroline Romano-Dutra; Francisco Silveira Guimaraes
Journal:  Neurotox Res       Date:  2013-06-27       Impact factor: 3.911

3.  Influence of intraventricular application of baclofen on arterial blood pressure and neurotransmitter concentrations in the hypothalamic paraventricular nucleus of rats.

Authors:  David Czell; Turgay Efe; Matthias Preuss; Markus D Schofer; Ralf Becker
Journal:  Neurochem Res       Date:  2011-10-09       Impact factor: 3.996

4.  Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.

Authors:  A Colzi; F d'Agostini; A M Cesura; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Changes in extracellular levels of dopamine metabolites in somatosensory cortex after peripheral denervation.

Authors:  M E Jiménez-Capdeville; T A Reader; E Molina-Holgado; R W Dykes
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

6.  On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

Authors:  Paola Devoto; Giovanna Flore
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

7.  Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum.

Authors:  K Matsuno; K H Matsunaga; S Mita
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

8.  Rapid effects of hearing song on catecholaminergic activity in the songbird auditory pathway.

Authors:  Lisa L Matragrano; Michaël Beaulieu; Jessica O Phillip; Ali I Rae; Sara E Sanford; Keith W Sockman; Donna L Maney
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

9.  Enriched environments enhance cognition, exploratory behaviour and brain physiological functions of Sparus aurata.

Authors:  P Arechavala-Lopez; J C Caballero-Froilán; M Jiménez-García; X Capó; S Tejada; J L Saraiva; A Sureda; D Moranta
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.